Beth CPA - Applied DNA Chief Officer
| APDN Stock | USD 0.16 0.01 5.88% |
Executive
Beth CPA is Chief Officer of Applied DNA Sciences
| Age | 48 |
| Address | 50 Health Sciences Drive, Stony Brook, NY, United States, 11790 |
| Phone | 631 240 8800 |
| Web | https://www.adnas.com |
Applied DNA Management Efficiency
The company has return on total asset (ROA) of (0.5744) % which means that it has lost $0.5744 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7608) %, meaning that it created substantial loss on money invested by shareholders. Applied DNA's management efficiency ratios could be used to measure how well Applied DNA manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -66.75. In addition to that, Return On Capital Employed is likely to grow to -60.39. At this time, Applied DNA's Intangibles To Total Assets are very stable compared to the past year. As of the 26th of November 2024, Asset Turnover is likely to grow to 0.93, while Total Current Assets are likely to drop about 5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jessica Olbricht | Biodesix | N/A | |
| Adrian Donohue | Trinity Biotech plc | N/A | |
| Senthil MD | Prenetics Global | 50 | |
| Claudia Levi | DarioHealth Corp | N/A | |
| Brielan Smiechowski | iSpecimen | N/A | |
| James MD | Biodesix | N/A | |
| Yvonne Wong | Prenetics Global | N/A | |
| Christian Haudenschild | Personalis | N/A | |
| Kieran OKane | Biodesix | 47 | |
| Robbie Lunt | Biodesix | N/A | |
| Limor Drezner | DarioHealth Corp | N/A | |
| Evan Cox | iSpecimen | N/A | |
| Sara Grubbs | Neuronetics | N/A | |
| Deepshikha Bhandari | Personalis | N/A | |
| Dror Bacher | DarioHealth Corp | 49 | |
| Andrea James | OncoCyte Corp | N/A | |
| Brian Harrigan | DarioHealth Corp | N/A | |
| Kat Parrella | DarioHealth Corp | N/A | |
| Joel Neoh | Prenetics Global | 40 | |
| Cory Anderson | Neuronetics | N/A | |
| Benjamin JD | Sera Prognostics | 45 | |
Management Performance
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.57 |
Applied DNA Sciences Leadership Team
Elected by the shareholders, the Applied DNA's board of directors comprises two types of representatives: Applied DNA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Applied. The board's role is to monitor Applied DNA's management team and ensure that shareholders' interests are well served. Applied DNA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Applied DNA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| Warren Pearlson, Sales Consultant | ||
| Tony Benson, Managing EMEA | ||
| Janice Meraglia, G VP | ||
| JD Esq, Chief Development | ||
| Joseph Magno, Sales Consultant | ||
| MeiLin Wan, VP Sales | ||
| John Shearman, Ex Bus | ||
| Beth CPA, Chief Officer | ||
| ScD Hayward, President Chairman | ||
| Judith Murrah, Chief COO | ||
| Sanjay Hurry, Executive Communications | ||
| Stephen Hughes, Director Programs |
Applied Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Applied DNA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.57 | ||||
| Profit Margin | (2.14) % | ||||
| Operating Margin | (4.20) % | ||||
| Current Valuation | (1.75 M) | ||||
| Shares Outstanding | 50.48 M | ||||
| Shares Owned By Insiders | 0.62 % | ||||
| Shares Owned By Institutions | 0.49 % | ||||
| Number Of Shares Shorted | 611.1 K | ||||
| Price To Earning | (5.06) X |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
| 0.87 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.82 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.82 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.82 | HD | Home Depot | PairCorr |
| 0.78 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.73) | Revenue Per Share 2.202 | Quarterly Revenue Growth (0.73) | Return On Assets (0.57) | Return On Equity (0.76) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.